Integrated Filing — IndAS


General information about company

Scrip Code 524091
NSE Symbol CARYSIL
MSEI Symbol NA
ISIN INE482D01024
Name of company CARYSIL LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-Apr-2024
Date of end of financial year 31-Mar-2025
Date of board meeting when results were approved 19-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 05-May-2025
Description of presentation currency INR (in Actuals)
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment Manufacturing of Kitchen and Bath Products
Start date and time of board meeting 19-May-2025   17:40:00
End date and time of board meeting 19-May-2025   20:25:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 2024-11-07
Indicate Company website link for updated RPT policy of the Company www.carysil.com
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? Yes
No. of times funds raised during the quarter 1
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
NA



Financial Results Ind-AS

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Income
Revenue from operations 1087100000 4203100000
Other income 33300000 132100000
Total income 1120400000 4335200000
2 Expenses
(a) Cost of materials consumed 391900000 1533700000
(b) Purchases of stock-in-trade 122300000 380900000
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade -78000000 -169100000
(d) Employee benefit expense 100000000 401600000
(e) Finance costs 27900000 119100000
(f) Depreciation, depletion and amortisation expense 70000000 268500000
(f) Other Expenses
1 Other expenses 337200000 1309000000
Total other expenses 337200000 1309000000
Total expenses 971300000 3843700000
3 Total profit before exceptional items and tax 149100000 491500000
4 Exceptional items 0 0
5 Total profit before tax 149100000 491500000
6 Tax expense
7 Current tax 34000000 124400000
8 Deferred tax 3400000 -1800000
9 Total tax expenses 37400000 122600000
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0 0
11 Net Profit Loss for the period from continuing operations 111700000 368900000
12 Profit (loss) from discontinued operations before tax 0 0
13 Tax expense of discontinued operations 0 0
14 Net profit (loss) from discontinued operation after tax 0 0
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0 0
16 Total profit (loss) for period 111700000 368900000
17 Other comprehensive income net of taxes 0 -1600000
18 Total Comprehensive Income for the period 111700000 367300000
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 56800000 56800000
Face value of equity share capital 2 2
27 Details of debt securities
22 Reserves excluding revaluation reserve 0
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 3.94 13.17
Diluted earnings (loss) per share from continuing operations 3.93 12.97
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 3.94 13.17
Diluted earnings (loss) per share from continuing and discontinued operations 3.93 12.97
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2024
Date of end of reporting period 31-Mar-2025
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 1970800000
Capital work-in-progress 111600000
Investment property 214400000
Goodwill 0
Other intangible assets 23100000
Intangible assets under development
Biological assets other than bearer plants
Investments accounted for using equity method 93700000
Non-current financial assets
Non-current investments 0
Trade receivables, non-current
Loans, non-current 473800000
Other non-current financial assets 159400000
Total non-current financial assets 633200000
Deferred tax assets (net)
Other non-current assets 69100000
Total non-current assets 3115900000
2 Current assets
Inventories 1076000000
Current financial asset
Current investments 0
Trade receivables, current 873900000
Cash and cash equivalents 14300000
Bank balance other than cash and cash equivalents 550700000
Loans, current 38100000
Other current financial assets 92700000
Total current financial assets 1569700000
Current tax assets (net) 511400000
Other current assets 199600000
Total current assets 3356700000
3 Non-current assets classified as held for sale
4 Regulatory deferral account debit balances and related deferred tax Assets
Total assets 6472600000
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 56800000
Other equity 4032300000
Total equity attributable to owners of parent 4089100000
Non controlling interest
Total equity 4089100000
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 169400000
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
Total Trade payable
Other non-current financial liabilities 81700000
Total non-current financial liabilities 251100000
Provisions, non-current 0
Deferred tax liabilities (net) 46400000
Deferred government grants, Non-current
Other non-current liabilities
Total non-current liabilities 297500000
Current liabilities
Current financial liabilities
Borrowings, current 1072300000
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 0
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 381600000
Total Trade payable 381600000
Other current financial liabilities 84100000
Total current financial liabilities 1538000000
Other current liabilities 33400000
Provisions, current 0
Current tax liabilities (Net) 514600000
Deferred government grants, Current
Total current liabilities 2086000000
3 Liabilities directly associated with assets in disposal group classified as held for sale
4 Regulatory deferral account credit balances and related deferred tax liability
Total liabilities 2383500000
Total equity and liabilites 6472600000
Disclosure of notes on assets and liabilities



Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Jan-2025 01-Apr-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether accounts are audited or unaudited Audited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Remeasurement of defined benefit plans (net of taxes) 0 -2200000
Total Amount of items that will not be reclassified to profit and loss 0 -2200000
2 Income tax relating to items that will not be reclassified to profit or loss 0 -600000
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss
5 Total Other comprehensive income 0 -1600000



Cash flow statement, indirect

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 2024-04-01
B Date of end of reporting period 2025-03-31
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
Part I Blue color marked fields are non-mandatory.
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 491500000
Adjustments for reconcile profit (loss)
Adjustments for finance costs 119100000
Adjustments for decrease (increase) in inventories -210400000
Adjustments for decrease (increase) in trade receivables, current -908800000
Adjustments for decrease (increase) in trade receivables, non-current 0
Adjustments for decrease (increase) in other current assets -54300000
Adjustments for decrease (increase) in other non-current assets 0
Adjustments for other financial assets, non-current 0
Adjustments for other financial assets, current 0
Adjustments for other bank balances 0
Adjustments for increase (decrease) in trade payables, current -61600000
Adjustments for increase (decrease) in trade payables, non-current 0
Adjustments for increase (decrease) in other current liabilities 0
Adjustments for increase (decrease) in other non-current liabilities 5800000
Adjustments for depreciation and amortisation expense 268500000
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 2800000
Adjustments for provisions, current 10200000
Adjustments for provisions, non-current 0
Adjustments for other financial liabilities, current 0
Adjustments for other financial liabilities, non-current 0
Adjustments for unrealised foreign exchange losses gains 0
Adjustments for dividend income 0
Adjustments for interest income 83600000
Adjustments for share-based payments 500000
Adjustments for fair value losses (gains) -800000
Adjustments for undistributed profits of associates 0
Other adjustments for which cash effects are investing or financing cash flow 0
Other adjustments to reconcile profit (loss) 0
Other adjustments for non-cash items 0
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0
Total adjustments for reconcile profit (loss) -912600000
Net cash flows from (used in) operations -421100000
Dividends received 0
Interest paid 0
Interest received 0
Income taxes paid (refund) 137400000
Other inflows (outflows) of cash 0
Net cash flows from (used in) operating activities -558500000
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0
Cash flows used in obtaining control of subsidiaries or other businesses 0
Other cash receipts from sales of equity or debt instruments of other entities 0
Other cash payments to acquire equity or debt instruments of other entities 0
Other cash receipts from sales of interests in joint ventures 0
Other cash payments to acquire interests in joint ventures 0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0
Proceeds from sales of property, plant and equipment 1100000
Purchase of property, plant and equipment 363300000
Proceeds from sales of investment property 0
Purchase of investment property 0
Proceeds from sales of intangible assets 0
Purchase of intangible assets 0
Proceeds from sales of intangible assets under development 0
Purchase of intangible assets under development 0
Proceeds from sales of goodwill 0
Purchase of goodwill 0
Proceeds from biological assets other than bearer plants 0
Purchase of biological assets other than bearer plants 0
Proceeds from government grants 0
Proceeds from sales of other long-term assets 0
Purchase of other long-term assets 42500000
Cash advances and loans made to other parties 0
Cash receipts from repayment of advances and loans made to other parties 0
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0
Dividends received 0
Interest received 83600000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 0
Net cash flows from (used in) investing activities -321100000
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0
Payments from changes in ownership interests in subsidiaries 0
Proceeds from issuing shares 1218300000
Proceeds from issuing other equity instruments 0
Payments to acquire or redeem entity's shares 0
Payments of other equity instruments 0
Proceeds from exercise of stock options 0
Proceeds from issuing debentures notes bonds etc 0
Proceeds from borrowings -123700000
Repayments of borrowings 0
Payments of lease liabilities 34200000
Dividends paid 56800000
Interest paid 117000000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 0
Net cash flows from (used in) financing activities 886600000
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 7000000
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0
Net increase (decrease) in cash and cash equivalents 7000000
Cash and cash equivalents cash flow statement at beginning of period 7300000
Cash and cash equivalents cash flow statement at end of period 14300000







Details of Impact of Audit Qualification

Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 PARK & Co. Yes 31-May-2028


Financial details

Sr. Particulars Audited Figures (as reported before adjusting for qualifications) Adjusted Figures (audited figures after adjusting for qualifications)
1 Turnover / Total income
2 Total Expenditure
3 Net Profit/(Loss)
4 Earnings Per Share
5 Total Assets
6 Total Liabilities
7 Net Worth




Signatories detail

Name of CEO / Managing director
Name of CFO
Name of audit committee chairman
Name of statutory auditor
Name of other signatory, if any, with designation
Place
Date



Statement on Deviation or Variation for proceeds of Public Issue, Rights Issue, Preferential Issue, Qualified Institutions Placement Etc. (1)

Mode of Fund Raising QIP
Description of mode of fund raising (Applicable in case of others is selected)
Date of Raising Funds 04-Jul-2024
Amount Raised 1250000000
Report filed for Quarter ended 31-Mar-2025
Monitoring Agency Applicable
Monitoring Agency Name, if applicable ICRA Limited
Is there a Deviation / Variation in use of funds raised No
If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders
If Yes, Date of shareholder Approval
Explanation for the Deviation / Variation Not Applicable
Comments of the Audit Committee after review No Comments
Comments of the auditors, if any No Comments
Sr. Original Object Modified Object, if any Original Allocation Modified allocation, if any Funds Utilised Amount of Deviation/Variation for the quarter according to applicable object Remarks if any
1 Funding the capital expenditure towards procurement and installation of machinery, equipment and moulds required for the Company’s existing and/or new manufacturing facilities (including advances to suppliers) NIL 625000000 0 74100000 0
2 Funding the Company’s working capital requirements NIL 312500000 0 312500000 0
3 General corporate purposes NIL 279000000 0 279000000 0


Signatory Details

Name of signatory Anand Sharma
Designation of person Chief Financial Officer
Place Mumbai
Date 19-May-2025




Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)

Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity /subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Carysil Limited Acrycol Minerals Limited Enterprises owned or significantly influenced by KMP or their relative Purchase of goods or services 200000000 Transactions are at arm's length basis 115400000 0 0
2 Carysil Limited Carysil Steel Limited Subsidiary Company Purchase of goods or services 75000000 Transactions are at arm's length basis 28100000 0 0
3 Carysil Limited Carysil Steel Limited Subsidiary Company Purchase of goods or services 50000000 Transactions are at arm's length basis 6000000 0 0
4 Carysil Limited Carysil Steel Limited Subsidiary Company Sale of goods or services 47500000 Transactions are at arm's length basis 4400000 0 0
5 Carysil Limited Carysil Steel Limited Subsidiary Company Any other transaction Royalty received 1300000 Transactions are at arm's length basis 500000 0 0
6 Carysil Limited Carysil Steel Limited Subsidiary Company Any other transaction Rent received 100000 Transactions are at arm's length basis 100000 0 0
7 Carysil Limited Carysil Steel Limited Subsidiary Company Any other transaction Commisision received 1500000 Transactions are at arm's length basis 100000 0 0
8 Carysil Limited Ashwanila Charitable Trust Enterprises owned or significantly influenced by KMP or their relatives Any other transaction Donation and CSR Activity 6000000 Transactions are at arm's length basis 4800000 0 0
9 Carysil Limited Ashwanila Charitable Trust Enterprises owned or significantly influenced by KMP or their relatives Any other transaction Rent received 100000 Approved 100000 0 0
10 Carysil Limited Carysil Gmbh, Germay Wholly Owned Subsidiary Sale of goods or services 0 Not Applicable 16600000 12200000 1800000
11 Carysil Limited Carysil Gmbh, Germay Wholly Owned Subsidiary Interest received 0 Not Applicable 1500000 0 0
12 Carysil Limited Carysil Gmbh, Germay Wholly Owned Subsidiary Any other transaction Royalty received 0 Not Applicable 100000 0 0
13 Carysil Limited Carysil Products Limited Step down Subsidiary of WOS Sale of goods or services 0 Not Applicable 155100000 122800000 93500000
14 Carysil Limited Carysil Online Limited Wholly Owned Subsidiary Sale of goods or services 0 Not Applicable 8400000 0 0
15 Carysil Limited Savan Godiawala Independent Director Any other transaction Sitiing Fees 0 Not Applicable 300000 0 0
16 Carysil Limited Rustam Mulla Independent Director Any other transaction Sitiing Fees 0 Not Applicable 300000 0 0
17 Carysil Limited Sonal Ambani Independent Director Any other transaction Sitiing Fees 0 Not Applicable 300000 0 0
18 Carysil Limited Anand Sharma Executive Director & CFO Any other transaction Remuneration 0 Not Applicable 3800000 0 0
19 Carysil Limited Chirag Parekh Chairman & Managing Director Any other transaction Remuneration 0 Not Applicable 30700000 0 0
20 Carysil Limited Reena Shah Company Secretary & Compliance Officer Any other transaction Remuneration 0 Not Applicable 1000000 0 0
21 Carysil Limited Carysil FZ LLC Wholly Owned Subsidiary Interest received 0 Not Applicable 1100000 0 0
22 Carysil Limited Pradyumna Vyas Independent Director Any other transaction Sitiing Fees 0 Not Applicable 300000 0 0
23 Carysil Limited Prabhakar Dalal Independent Director Any other transaction Sitiing Fees 0 Not Applicable 300000 0 0
24 Carysil Limited Katja Larsen Independent Director Any other transaction Sitiing Fees 0 Not Applicable 300000 0 0
25 Carysil Limited Rhea Parekh Place of Profit Any other transaction Short term employee benefit 0 Approved 2000000 0 0
26 Carysil Limited Carysil USA Inc. Wholly Owned Subsidiary Loan 0 Approved 74500000 0 0
27 Carysil Limited Carysil USA Inc. Wholly Owned Subsidiary Interest received 0 Approved 36300000 0 0
28 Carysil Limited Carysil UK Limited Wholly Owned Subsidiary Any other transaction Commission received 0 Not Applicable 1000000 0 0
29 Carysil Limited Carysil Online Limited Wholly Owned Subsidiary Any other transaction Business Income 0 Not Applicable 400000 0 0
30 Carysil Limited Carysil Ankastre Sistemleri Ticaret Limited Sirketi Wholly Owned Subsidiary Loan 0 Not Applicable 2600000 0 0
31 Carysil Limited Carysil Ankastre Sistemleri Ticaret Limited Sirketi Wholly Owned Subsidiary Interest received 0 Not Applicable 400000 0 0
32 Carysil Limited United Granite LLC Step down Subsidiary of WOS Sale of goods or services 0 Not Applicable 12300000 0 0
33 Carysil Limited Carysil Products Limited Step down Subsidiary of WOS Any other transaction Commission paid 0 Not Applicable 14600000 0 0
34 Carysil Limited Carysil Gmbh, Germay Subsidiary Company Any other transaction Commission paid 0 Not Applicable 7700000 0 0
35 Carysil Steel Limited Carysil Online Limited Subsidiary Company Sale of goods or services 0 Not Applicable 700000 0 0
36 Carysil Steel Limited Carysil Products Limited Subsidiary Company Sale of goods or services 0 Not Applicable 11700000 0 0
37 Carysil USA Inc. United Granite LLC Step down Subsidiary of WOS Loan 0 Not Applicable 12000000 0 0
Total value of transaction during the reporting period 555800000





Format for Disclosing Outstanding Default on Loans and Debt Securities

Sr. No. Particulars Amount Remarks
1. Loans / revolving facilities like cash credit from banks / financial institutions
A Total amount outstanding as on date
B Of the total amount outstanding, amount of default as on date
2. Unlisted debt securities i.e. NCDs and NCRPS
A Total amount outstanding as on date
B Of the total amount outstanding, amount of default as on date
3. Total financial indebtedness of the listed entity including short-term and long-term debt